Healthlynked Corp (HLYK)

$3.00 -0.20 (-6.25%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 300
Avg Vol 3,172
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 6%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

HealthLynked Corp., a healthcare technology company, operates a cloud-based patient information network and record archiving system in the United States. It operates through three segments: Digital Healthcare, Medical Distribution, and Health Services. The Digital Healthcare segment develops, operates, and manages HealthLynked Network, an online personal medical information and record archive system that facilitates efficient management of medical records and care, allows seamless patient appoin...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 800 928 7144
Address:
1265 Creekside Parkway, Suite 302, Naples, United States
GordoHLYK13
GordoHLYK13 Feb. 21 at 7:07 PM
$NEO $HLYK 2026 Together We Fly https://youtu.be/ztJVbDCifO8?si=1jToNIeu3ri5AA4u
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 21 at 1:27 PM
$HLYK HealthLynked (HLYK): Top 6 Catalysts 1. Nasdaq S-1 Filed: Official application for uplisting is active (targeting $4.00–$6.00 range). 2. Nasdaq Debut: Moving from OTC to the "Big Board" opens the door to institutional and retail millions. 3. Insider Confidence: Dr. Dent consolidated $5.7M in debt into a note convertible at $4.25 per share. 4. Payer Pilot: New partnership with PBACO to launch an AI pilot program with UnitedHealthcare. 5. ARi AI Rollout: "National Initiative" launched to integrate the AI assistant with pharma and research giants. 6. Low Float Physics: Only 1.9M shares available; any major news could trigger a "vertical" price squeeze. $NEO
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 21 at 1:26 PM
$NEO NeoGenomics (NEO): Top 7 Catalysts 1. RaDaR ST Launch: Full U.S. clinical rollout of the "next-gen" cancer test is starting this month (Feb 2026). 2. Lee Health Lab: NEO’s partnership anchored in Lee Health’s new $150M molecular lab expansion. 3. The "Beat & Raise": Q1 earnings (May 2026) likely to smash the "conservative" 2026 guidance. 4. NGS Growth: Revenue for high-profit sequencing is surging at 23% year-over-year. 5. Sales Force Blitz: Expanding to 165 oncology specialists this year to drive massive test volume. 6. Reimbursement Win: MolDx/Medicare pricing for new liquid biopsies is locked in for 2026. 7. Buyout Potential: Dominant Florida footprint makes NEO a prime acquisition target for Quest or LabCorp. $HLYK
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 21 at 12:55 PM
$HLYK Nasdaq S-1 Filed! Dr. Dent Betting Big! The transformation is real. Dr. Dent (founder of $NEO repeating the playbook. 🩺 The News: HealthLynked just filed its S-1 for Nasdaq uplisting with a target range of $4.00–$6.00. The TCOB Checklist: • Founder Confidence: Dr. Dent just consolidated $5.7M in debt into a note convertible at $4.25. He isn't just the CEO; he's the biggest bull. • Commercial Scalability: ARI AI platform is moving into payer/employer channels (high-margin recurring revenue). • Nasdaq Ready: Cleanup of governance and reporting is done. • Local Synergy: Strategic positioning with Southwest FL medical heavyweights (Millennium, Lee Health, NCH).
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 21 at 12:54 PM
$NEO While Others Panic! Don't let the post-earnings shakeout fool you. 📊 Dig Deep: NEO just beat Q4 Rev & EPS, hitting its 10th straight quarter of positive Adj. EBITDA. Volume spike at $9.89 + RSI at 26 = classic "capitulation" bottom. Why I’m Bullish: • Institutional Support: Zacks #2 (Buy) upgrade just hit. • Insiders are IN: COO Warren Stone’s recent Form 4 shows he’s holding 120k+ shares and huge options at $13-$19. He only sold a fraction for taxes. • Local Moat: Deeply integrated with Lee Health's new $150M lab expansion and NCH oncology. • RaDaR ST: Full clinical launch this month. The "dishes are done." Accumulating here. 🚀 #Oncology #FortMyers #Value Watch out $NTRA $HLYK CEO Dent $NEO founder
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 8 at 5:46 PM
$HLYK The $HYLK Bullish Punch CEO Dr. Michael Dent is going "All-In." This filing is a massive signal of insider confidence for three key reasons: • The Ultimate Buy-In: The CEO converted $5.7M of personal advances and unpaid salary into a secured note. He’s not walking away; he’s doubling down on the company’s survival and success. • High Expectations: The conversion price is set at $4.25 per share. By locking in this price, the CEO is signaling he believes the stock is worth significantly more than its current trading level. • Balance Sheet Cleanup: He’s rolled "messy" short-term debt and old liabilities into one 3-year note, giving the company a clear runway until 2029 to execute its growth plan. The Bottom Line: The captain isn't just staying with the ship; he’s buying a bigger stake at a premium. Sec filing firm 8k released on Friday after market closed This week is bullish $TDOC $NEO
1 · Reply
GordoHLYK13
GordoHLYK13 Jan. 27 at 2:02 PM
$HLYK Calm before the storm — NASDAQ: HLYK is quietly building leverage as its patient-centric healthcare network and data-driven platform connects providers, patients, and medical data into one ecosystem, positioning the company for scalable growth, monetization, and broader adoption while the market still sleeps.
0 · Reply
wheresdannynow
wheresdannynow Jan. 26 at 6:22 PM
BIOTECH MOVERS 🟢 TOP GAINERS: 1. $MHUAF +32.8% 2. $GTHP +30.0% 3. $CHRS +29.6% 🔴 TOP LOSERS: 1. $SONN -59.4% 2. $MHUA -45.7% 3. $HLYK -31.8%
0 · Reply
TheShredder
TheShredder Jan. 23 at 8:52 PM
$HLYK if they don’t stay above 4 they have to try again…not hard to see what they are doing here but u need some sort of news to get people to buy coming out of the reverse split otherwise you get exposed…Mr. Dent is trying to take the shortcut. Show us a reason to buy and u will get your uplist
0 · Reply
BioBum
BioBum Jan. 23 at 1:10 PM
$HLYK No liquidity
0 · Reply
Latest News on HLYK
No data available.
GordoHLYK13
GordoHLYK13 Feb. 21 at 7:07 PM
$NEO $HLYK 2026 Together We Fly https://youtu.be/ztJVbDCifO8?si=1jToNIeu3ri5AA4u
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 21 at 1:27 PM
$HLYK HealthLynked (HLYK): Top 6 Catalysts 1. Nasdaq S-1 Filed: Official application for uplisting is active (targeting $4.00–$6.00 range). 2. Nasdaq Debut: Moving from OTC to the "Big Board" opens the door to institutional and retail millions. 3. Insider Confidence: Dr. Dent consolidated $5.7M in debt into a note convertible at $4.25 per share. 4. Payer Pilot: New partnership with PBACO to launch an AI pilot program with UnitedHealthcare. 5. ARi AI Rollout: "National Initiative" launched to integrate the AI assistant with pharma and research giants. 6. Low Float Physics: Only 1.9M shares available; any major news could trigger a "vertical" price squeeze. $NEO
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 21 at 1:26 PM
$NEO NeoGenomics (NEO): Top 7 Catalysts 1. RaDaR ST Launch: Full U.S. clinical rollout of the "next-gen" cancer test is starting this month (Feb 2026). 2. Lee Health Lab: NEO’s partnership anchored in Lee Health’s new $150M molecular lab expansion. 3. The "Beat & Raise": Q1 earnings (May 2026) likely to smash the "conservative" 2026 guidance. 4. NGS Growth: Revenue for high-profit sequencing is surging at 23% year-over-year. 5. Sales Force Blitz: Expanding to 165 oncology specialists this year to drive massive test volume. 6. Reimbursement Win: MolDx/Medicare pricing for new liquid biopsies is locked in for 2026. 7. Buyout Potential: Dominant Florida footprint makes NEO a prime acquisition target for Quest or LabCorp. $HLYK
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 21 at 12:55 PM
$HLYK Nasdaq S-1 Filed! Dr. Dent Betting Big! The transformation is real. Dr. Dent (founder of $NEO repeating the playbook. 🩺 The News: HealthLynked just filed its S-1 for Nasdaq uplisting with a target range of $4.00–$6.00. The TCOB Checklist: • Founder Confidence: Dr. Dent just consolidated $5.7M in debt into a note convertible at $4.25. He isn't just the CEO; he's the biggest bull. • Commercial Scalability: ARI AI platform is moving into payer/employer channels (high-margin recurring revenue). • Nasdaq Ready: Cleanup of governance and reporting is done. • Local Synergy: Strategic positioning with Southwest FL medical heavyweights (Millennium, Lee Health, NCH).
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 21 at 12:54 PM
$NEO While Others Panic! Don't let the post-earnings shakeout fool you. 📊 Dig Deep: NEO just beat Q4 Rev & EPS, hitting its 10th straight quarter of positive Adj. EBITDA. Volume spike at $9.89 + RSI at 26 = classic "capitulation" bottom. Why I’m Bullish: • Institutional Support: Zacks #2 (Buy) upgrade just hit. • Insiders are IN: COO Warren Stone’s recent Form 4 shows he’s holding 120k+ shares and huge options at $13-$19. He only sold a fraction for taxes. • Local Moat: Deeply integrated with Lee Health's new $150M lab expansion and NCH oncology. • RaDaR ST: Full clinical launch this month. The "dishes are done." Accumulating here. 🚀 #Oncology #FortMyers #Value Watch out $NTRA $HLYK CEO Dent $NEO founder
0 · Reply
GordoHLYK13
GordoHLYK13 Feb. 8 at 5:46 PM
$HLYK The $HYLK Bullish Punch CEO Dr. Michael Dent is going "All-In." This filing is a massive signal of insider confidence for three key reasons: • The Ultimate Buy-In: The CEO converted $5.7M of personal advances and unpaid salary into a secured note. He’s not walking away; he’s doubling down on the company’s survival and success. • High Expectations: The conversion price is set at $4.25 per share. By locking in this price, the CEO is signaling he believes the stock is worth significantly more than its current trading level. • Balance Sheet Cleanup: He’s rolled "messy" short-term debt and old liabilities into one 3-year note, giving the company a clear runway until 2029 to execute its growth plan. The Bottom Line: The captain isn't just staying with the ship; he’s buying a bigger stake at a premium. Sec filing firm 8k released on Friday after market closed This week is bullish $TDOC $NEO
1 · Reply
GordoHLYK13
GordoHLYK13 Jan. 27 at 2:02 PM
$HLYK Calm before the storm — NASDAQ: HLYK is quietly building leverage as its patient-centric healthcare network and data-driven platform connects providers, patients, and medical data into one ecosystem, positioning the company for scalable growth, monetization, and broader adoption while the market still sleeps.
0 · Reply
wheresdannynow
wheresdannynow Jan. 26 at 6:22 PM
BIOTECH MOVERS 🟢 TOP GAINERS: 1. $MHUAF +32.8% 2. $GTHP +30.0% 3. $CHRS +29.6% 🔴 TOP LOSERS: 1. $SONN -59.4% 2. $MHUA -45.7% 3. $HLYK -31.8%
0 · Reply
TheShredder
TheShredder Jan. 23 at 8:52 PM
$HLYK if they don’t stay above 4 they have to try again…not hard to see what they are doing here but u need some sort of news to get people to buy coming out of the reverse split otherwise you get exposed…Mr. Dent is trying to take the shortcut. Show us a reason to buy and u will get your uplist
0 · Reply
BioBum
BioBum Jan. 23 at 1:10 PM
$HLYK No liquidity
0 · Reply
GordoHLYK13
GordoHLYK13 Jan. 22 at 5:45 PM
$HLYK Most people see a "healthcare company," but the market is starting to price in a Global AI Health Network. ✅ The Momentum: 10 days of straight green. From $1.50 to $6.00+ in three weeks. 📈 ✅ The Big Move: Nasdaq uplisting application is IN. Moving from OTC to the Big Board in H1 2026 ✅ The Tech: Over 1 Million members integrated into their patented ARi AI ecosystem. 🤖🏥 ✅ The Team: New heavy-hitter COO and insurance experts added to the board. The gap is closing. Don't say you weren't watching. #HLYK #Nasdaq #AI #HealthTech HealthLynked is bridging the gap between legacy healthcare and AI-driven medicine. They have the tech, they have the data, and now they have the momentum to hit the Big Board #arthrex
0 · Reply
Conquistador69
Conquistador69 Jan. 22 at 5:04 PM
$HLYK IM PRAYING THIS HOLDS NOW
0 · Reply
GordoHLYK13
GordoHLYK13 Jan. 22 at 3:03 PM
My two diamonds $HLYK and $HYLN
1 · Reply
GordoHLYK13
GordoHLYK13 Jan. 22 at 10:22 AM
$HLYK HealthLynked ($HLYK) isn't just a telehealth play; they own the patent on the 'Digital Waiting Room.' 🏥 No more clipboards—their HUB tech automates patient check-ins via secure wireless detection. Strong IP + AI integration = a massive moat for the 2026 Nasdaq push. 🚀 #HealthTech #StockMarket Patent US 11,600,395 is the backbone of $HLYK’s ecosystem. It turns every doctor's office into a smart-hub that recognizes patients instantly. With a Nasdaq uplist on the horizon for 2026, the tech is finally meeting the opportunity. 📈 #ValueInvesting #DigitalHealth HLYK owns the 'Fast Pass' for healthcare. 🛡️ Their patented HUB tech kills the manual check-in and secures patient data before you even sit down. The foundation for a 2026 breakout is set. 💎
0 · Reply
GordoHLYK13
GordoHLYK13 Jan. 21 at 10:09 PM
$HLYK $HLYK: The Nasdaq Mission is Full Go! 🚀🏥 While everyone was sleeping, HealthLynked just rebuilt their entire engine for the big leagues. We’re talking a micro-float (under 2M shares) meeting a massive wave of "Uplisting" momentum. Look at the chess moves: ✅ New COO brought in specifically for the Nasdaq jump. ✅ PBACO Partnership giving them access to 15k+ doctors. ✅ AI + Healthcare integration that’s actually scaling. With a float this tight, any volume at all sends this into price discovery mode. We aren't just trading a penny stock anymore; we’re watching a company bridge the gap to the majors. The RSI is screaming, the charts are vertical, and the mission is clear. Don't chase the tail—trade the trend. 📈💎 #HLYK #NasdaqBound #LowFloat #HealthTech
0 · Reply
TheShredder
TheShredder Jan. 21 at 7:19 PM
$HLYK so we reverse split with the same revenue and all of a sudden it runs like they just cured cancer? I’m in deep on this but make it make sense?
1 · Reply
GordoHLYK13
GordoHLYK13 Jan. 21 at 3:49 PM
$HLYK Check out $PAVM — that same setup could play out with HealthLynked. Low float + real, positive news is a powerful combo. PAVM even went through a split, and the stock still ran. When fundamentals meet a tight float, moves can be explosive. Buckle up
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 21 at 11:12 AM
$HLYK Really good write-up that perfectly summarizes HLYK's present situation. So if you want to bring your HLYK knowledge up to date or just discover HLYK, this is required reading. https://everyticker.com/quote/HLYK/analysis/healthlynked-s-digital-pivot-a-last-ditch-bid-for-survival-at-1-80-otc-hlyk
1 · Reply
GordoHLYK13
GordoHLYK13 Jan. 21 at 8:17 AM
$HLYK HLYK ripping ~$4 in a week shows what can happen when real catalysts hit a thin float — moves that are fuelled by structural liquidity and fresh news, not just random hype. HealthLynked isn’t sitting still: it’s tightening up its share structure via a reverse split to boost price and support institutional interest, prepping for a Nasdaq uplist, launching its AI health assistant ‘ARI,’ expanding telemedicine & payer-integration partnerships, and locking in strategic advisors to accelerate growth. Thin float + real news = explosive potential as fundamentals and visibility start to sync. $NEO $TDOC
0 · Reply
TaurusBull76
TaurusBull76 Jan. 20 at 6:42 PM
$HLYK regardless of my dissatisfaction with the RS I am happy for them. Hoping for lots of growth and opportunities.
0 · Reply
GordoHLYK13
GordoHLYK13 Jan. 20 at 3:42 PM
$HLYK $HLYK is firing on all cylinders — planning a Nasdaq uplist in 2026, expanding strategic healthcare partnerships, strengthening payer integrations, and scaling its AI-driven care platform nationwide. Real progress + real catalysts = big upside potential ahead! 🚀 
1 · Reply
GordoHLYK13
GordoHLYK13 Jan. 18 at 3:40 PM
$HLYK https://youtu.be/wElWiSzp9z4?si=HzheKpuaR5QTIkIn
0 · Reply